Home > Insider Trading > Filing (0001181431-13-000828)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1492426	Horizon Pharma Inc.	HZNP	Pharmaceutical Preparations (2834)	272179987

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1523386	Michael Adatto	C/O Horizon Pharma, Inc. 520 Lake Cook Road, Suite 520 Deerfield IL 60015	Svp, Managed Care & Comm. Dev.	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2012-12-31	22,500	$0.00	29,909	No	4	A	Direct
Common Stock	Disposition	2013-01-02	6,998	$2.36	22,911	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee stock options (right to buy)	Acquisiton	2013-01-02	21,750	$0.00	21,750	$2.40
Common Stock	Restricted stock units	Acquisiton	2013-01-02	19,800	$0.00	19,800	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
21,750		2023-01-01	No	4	A	Direct
19,800			No	4	A	Direct

Footnotes

On January 3, 2012, the reporting person was granted restricted stock units which vest upon the achievement of certain performance criteria. On December 31, 2012, 22,500 of these restricted stock units vested in connection with the achievement of certain of these performance related goals. No unvested restricted stock units with respect to this grant were outstanding after the completion of this transaction.
Includes 2,910 shares of the Company's common stock acquired pursuant to an employee stock purchase program.
Reflects shares of common stock surrendered via open market sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in December 2012, in order to satisfy certain tax withholding obligations.
The shares subject to the option vest and become exercisable in forty-eight equal monthly installments from the vesting commencement date of January 2, 2013.
Each restricted stock unit represents a contingent right to receive one share of Horizon Pharma, Inc. common stock.
The restricted stock units vest in four equal annual installments beginning January 2, 2014.